Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugging Fuzzy Complexes in Transcription.

Bonnie G Su1,2,3, Matthew J Henley1,2

  • 1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.

Frontiers in Molecular Biosciences
|January 7, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pause Patrol: Negative Elongation Factor's Role in Promoter-Proximal Pausing and Beyond.

Journal of molecular biology·2024
Same author

Distinct negative elongation factor conformations regulate RNA polymerase II promoter-proximal pausing.

Molecular cell·2024
Same author

Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization.

Structure (London, England : 1993)·2023
Same author

Nailing Down a Notoriously Elusive Cancer Target: Direct Inhibition of MYC by a Covalent Small Molecule.

Cell chemical biology·2021
Same author

Molecular recognition of pre-tRNA by <i>Arabidopsis</i> protein-only Ribonuclease P.

RNA (New York, N.Y.)·2017
Same author

Crystal structure of O-ethyl N-(eth-oxy-carbon-yl)thio-carbamate.

Acta crystallographica. Section E, Crystallographic communications·2015

Transcription factors (TFs) present unique drug discovery challenges due to their inherent structural disorder, termed "fuzziness." This summary explores how biophysical and chemical biology methods can overcome these obstacles for TF-targeted therapeutics.

Area of Science:

  • Biochemistry
  • Drug Discovery
  • Structural Biology

Background:

  • Transcription factors (TFs) are crucial regulators of gene expression.
  • TFs are increasingly recognized as valuable drug targets.
  • The intrinsic disorder and "fuzziness" of TFs pose significant challenges for drug development.

Purpose of the Study:

  • To discuss the impact of TF fuzziness on drug discovery.
  • To highlight the limitations of traditional drug design and screening for TFs.
  • To propose novel approaches for overcoming TF disorder in drug development.

Main Methods:

  • Literature review and discussion of TF properties.
  • Analysis of challenges in targeting disordered proteins.
  • Exploration of modern biophysical and chemical biology techniques.
Keywords:
biophysicschemical biologydrug discoveryfuzzy protein protein interactionstranscription factors

Related Experiment Videos

Main Results:

  • TF fuzziness complicates conventional drug design and screening.
  • Disordered nature of TFs requires specialized approaches.
  • Synergistic application of advanced methods can address TF targeting challenges.

Conclusions:

  • Overcoming TF disorder is key to unlocking their therapeutic potential.
  • Modern biophysical and chemical biology offer promising solutions.
  • Targeting TFs effectively requires innovative drug discovery strategies.